• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TIGIT-Fc 作为一种潜在的治疗胎儿母体耐受的药物。

TIGIT-Fc as a Potential Therapeutic Agent for Fetomaternal Tolerance.

机构信息

Department of Assisted Reproduction, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Department of Biophysics, College of Basic Medical Sciences, Second Military Medical University, Shanghai, China.

出版信息

Front Immunol. 2021 Mar 25;12:649135. doi: 10.3389/fimmu.2021.649135. eCollection 2021.

DOI:10.3389/fimmu.2021.649135
PMID:33841433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8027249/
Abstract

The perfect synchronization of maternal immune-endocrine mechanisms and those of the fetus is necessary for a successful pregnancy. In this report, decidual immune cells at the maternal-fetal interface were detected that expressed TIGIT (T cell immunoreceptor with Ig and ITIM domains), which is a co-inhibitory receptor that triggers immunological tolerance. We generated recombinant TIGIT-Fc fusion proteins by linking the extracellular domain of TIGIT and silent Fc fragments. The treatment with TIGIT-Fc of human decidual antigen presenting cells (APCs), the decidual dendritic cells (dDCs), and decidual macrophages (dMϕs) increased the production of interleukin 10 and induced the decidua APCs to powerfully polarize the decidual CD4 T cells toward a classic T2 phenotype. We further proposed that Notch signaling shows a pivotal effect on the transcriptional regulation in decidual immune cell subsets. Moreover, the administration of TIGIT-Fc to CBA/J pregnant mice at preimplantation induced CD4 forkhead box P3 (Foxp3) regulatory T cells and tolerogenic dendritic cells and increased pregnancy rates in an abortion-prone animal model stress. The results suggested the therapeutic potential of the TIGIT-Fc fusion protein in reinstating immune tolerance in failing pregnancies.

摘要

母体免疫-内分泌机制与胎儿机制的完美同步是成功妊娠所必需的。在本报告中,我们检测到了母体-胎儿界面的蜕膜免疫细胞表达 T 细胞免疫受体酪氨酸抑制基序(T cell immunoreceptor with Ig and ITIM domains,TIGIT),它是一种触发免疫耐受的共抑制受体。我们通过连接 TIGIT 的细胞外结构域和沉默的 Fc 片段生成了重组 TIGIT-Fc 融合蛋白。TIGIT-Fc 处理人蜕膜抗原呈递细胞(antigen presenting cells,APCs)、蜕膜树突状细胞(dendritic cells,dDCs)和蜕膜巨噬细胞(macrophages,dMϕs)增加了白细胞介素 10 的产生,并诱导蜕膜 APC 强烈地将蜕膜 CD4 T 细胞向经典 T2 表型极化。我们进一步提出,Notch 信号在蜕膜免疫细胞亚群的转录调控中显示出关键作用。此外,在植入前将 TIGIT-Fc 给予易流产的 CBA/J 怀孕小鼠,诱导 CD4 叉头框 P3(forkhead box P3,Foxp3)调节性 T 细胞和耐受树突状细胞,并增加流产倾向动物模型中的妊娠率。这些结果表明,TIGIT-Fc 融合蛋白在恢复失败妊娠中的免疫耐受方面具有治疗潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c33/8027249/a83705d2acae/fimmu-12-649135-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c33/8027249/77d6b5ce34d3/fimmu-12-649135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c33/8027249/7fd93c49452d/fimmu-12-649135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c33/8027249/513d2c957084/fimmu-12-649135-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c33/8027249/bdc3050b936e/fimmu-12-649135-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c33/8027249/a83705d2acae/fimmu-12-649135-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c33/8027249/77d6b5ce34d3/fimmu-12-649135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c33/8027249/7fd93c49452d/fimmu-12-649135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c33/8027249/513d2c957084/fimmu-12-649135-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c33/8027249/bdc3050b936e/fimmu-12-649135-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c33/8027249/a83705d2acae/fimmu-12-649135-g005.jpg

相似文献

1
TIGIT-Fc as a Potential Therapeutic Agent for Fetomaternal Tolerance.TIGIT-Fc 作为一种潜在的治疗胎儿母体耐受的药物。
Front Immunol. 2021 Mar 25;12:649135. doi: 10.3389/fimmu.2021.649135. eCollection 2021.
2
Three Types of Functional Regulatory T Cells Control T Cell Responses at the Human Maternal-Fetal Interface.三种功能性调节性 T 细胞控制着人类母胎界面的 T 细胞反应。
Cell Rep. 2019 May 28;27(9):2537-2547.e5. doi: 10.1016/j.celrep.2019.04.109.
3
The regulatory role of thymic stromal lymphopoietin (TSLP) in maternal-fetal immune tolerance during early human pregnancy.胸腺基质淋巴细胞生成素(TSLP)在人类妊娠早期母胎免疫耐受中的调节作用。
J Reprod Immunol. 2009 Dec;83(1-2):106-8. doi: 10.1016/j.jri.2009.07.015. Epub 2009 Oct 25.
4
TIGIT-Fc alleviates acute graft-versus-host disease by suppressing CTL activation via promoting the generation of immunoregulatory dendritic cells.TIGIT-Fc 通过促进免疫调节树突状细胞的生成来抑制 CTL 的激活,从而缓解急性移植物抗宿主病。
Biochim Biophys Acta Mol Basis Dis. 2018 Sep;1864(9 Pt B):3085-3098. doi: 10.1016/j.bbadis.2018.06.022. Epub 2018 Jun 28.
5
Programmed cell death-1 (PD-1) and T-cell immunoglobulin mucin-3 (Tim-3) regulate CD4+ T cells to induce Type 2 helper T cell (Th2) bias at the maternal-fetal interface.程序性细胞死亡蛋白-1(PD-1)和 T 细胞免疫球蛋白黏蛋白-3(Tim-3)调节 CD4+T 细胞,在母体-胎儿界面诱导 2 型辅助性 T 细胞(Th2)偏向。
Hum Reprod. 2016 Apr;31(4):700-11. doi: 10.1093/humrep/dew019. Epub 2016 Feb 16.
6
RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization.RANKL 介导的胎儿与母亲之间的和谐对话通过诱导蜕膜 M2 巨噬细胞极化来保证妊娠的顺利进行。
Cell Death Dis. 2017 Oct 12;8(10):e3105. doi: 10.1038/cddis.2017.505.
7
Decidual stromal cells support tolerance at the human foetal-maternal interface by inducing regulatory M2 macrophages and regulatory T-cells.蜕膜基质细胞通过诱导调节性 M2 巨噬细胞和调节性 T 细胞来支持人胎儿-母体界面的耐受。
J Reprod Immunol. 2021 Aug;146:103330. doi: 10.1016/j.jri.2021.103330. Epub 2021 May 12.
8
The TIGIT/CD226 axis regulates human T cell function.TIGIT/CD226 轴调节人类 T 细胞功能。
J Immunol. 2012 Apr 15;188(8):3869-75. doi: 10.4049/jimmunol.1103627. Epub 2012 Mar 16.
9
Tim-3/CTLA-4 pathways regulate decidual immune cells-extravillous trophoblasts interaction by IL-4 and IL-10.Tim-3/CTLA-4 通路通过 IL-4 和 IL-10 调节蜕膜免疫细胞-绒毛外滋养层细胞的相互作用。
FASEB J. 2021 Aug;35(8):e21754. doi: 10.1096/fj.202100142R.
10
Correlations of the expression of γδ T cells and their co-stimulatory molecules TIGIT, PD-1, ICOS and BTLA with PR and PIBF in the peripheral blood and decidual tissues of women with unexplained recurrent spontaneous abortion.γδ T 细胞及其共刺激分子 TIGIT、PD-1、ICOS 和 BTLA 的表达与不明原因复发性自然流产患者外周血和蜕膜组织中 PR 和 PIBF 的相关性。
Clin Exp Immunol. 2021 Jan;203(1):55-65. doi: 10.1111/cei.13534. Epub 2020 Oct 28.

引用本文的文献

1
Differential Immune Checkpoint Expression in CD4 and CD4 NKT Cell Populations During Healthy Pregnancy.健康孕期CD4和CD4 NKT细胞群体中免疫检查点的差异表达
Int J Mol Sci. 2025 Aug 19;26(16):8022. doi: 10.3390/ijms26168022.
2
The role of dendritic cells in recurrent pregnancy loss.树突状细胞在复发性流产中的作用。
Immunol Res. 2025 Jul 21;73(1):108. doi: 10.1007/s12026-025-09664-z.
3
CD8+ and CD8- NK Cells and Immune Checkpoint Networks in Peripheral Blood During Healthy Pregnancy.健康孕期外周血中的CD8 +和CD8 -自然杀伤细胞与免疫检查点网络

本文引用的文献

1
Three Types of Functional Regulatory T Cells Control T Cell Responses at the Human Maternal-Fetal Interface.三种功能性调节性 T 细胞控制着人类母胎界面的 T 细胞反应。
Cell Rep. 2019 May 28;27(9):2537-2547.e5. doi: 10.1016/j.celrep.2019.04.109.
2
Treatment of murine lupus with TIGIT-Ig.用 TIGIT-Ig 治疗狼疮鼠。
Clin Immunol. 2019 Jun;203:72-80. doi: 10.1016/j.clim.2019.04.007. Epub 2019 Apr 18.
3
EGFR/Notch Antagonists Enhance the Response to Inhibitors of the PI3K-Akt Pathway by Decreasing Tumor-Initiating Cell Frequency.
Int J Mol Sci. 2025 Jan 6;26(1):428. doi: 10.3390/ijms26010428.
4
Sex differences in human pre-gastrulation embryos.人类原肠胚形成前胚胎中的性别差异。
Sci China Life Sci. 2025 Feb;68(2):397-415. doi: 10.1007/s11427-024-2721-y. Epub 2024 Sep 24.
5
Treg-Specific CD226 Deletion Reduces Diabetes Incidence in NOD Mice by Improving Regulatory T-Cell Stability.通过提高调节性T细胞稳定性,Treg特异性CD226缺失降低NOD小鼠的糖尿病发病率。
Diabetes. 2023 Nov 1;72(11):1629-1640. doi: 10.2337/db23-0307.
6
Paradoxical expression of NRP1 in decidual stromal and immune cells reveals a novel inflammation balancing mechanism during early pregnancy.NRP1 在蜕膜基质和免疫细胞中的矛盾表达揭示了早孕期间一种新的炎症平衡机制。
Inflamm Res. 2023 Jul;72(7):1341-1357. doi: 10.1007/s00011-023-01734-y. Epub 2023 Jun 16.
7
Immunomodulatory role of metalloproteases in cancers: Current progress and future trends.金属蛋白酶在癌症中的免疫调节作用:当前进展和未来趋势。
Front Immunol. 2022 Dec 16;13:1064033. doi: 10.3389/fimmu.2022.1064033. eCollection 2022.
8
LIGHT (TNFSF14) Costimulation Enhances Myeloid Cell Activation and Antitumor Immunity in the Setting of PD-1/PD-L1 and TIGIT Checkpoint Blockade.LIGHT(TNFSF14)共刺激增强了 PD-1/PD-L1 和 TIGIT 检查点阻断条件下的髓样细胞激活和抗肿瘤免疫。
J Immunol. 2022 Aug 1;209(3):510-525. doi: 10.4049/jimmunol.2101175. Epub 2022 Jul 11.
9
What Inhibits Natural Killers' Performance in Tumour.肿瘤如何抑制自然杀伤细胞的功能。
Int J Mol Sci. 2022 Jun 24;23(13):7030. doi: 10.3390/ijms23137030.
表皮生长因子受体/Notch 拮抗剂通过降低肿瘤起始细胞频率增强对 PI3K-Akt 通路抑制剂的反应。
Clin Cancer Res. 2019 May 1;25(9):2835-2847. doi: 10.1158/1078-0432.CCR-18-2732. Epub 2019 Jan 22.
4
Antagonism of EGFR and Notch limits resistance to EGFR inhibitors and radiation by decreasing tumor-initiating cell frequency.EGFR 和 Notch 的拮抗作用通过降低肿瘤起始细胞频率来限制对 EGFR 抑制剂和辐射的抵抗。
Sci Transl Med. 2017 Mar 8;9(380). doi: 10.1126/scitranslmed.aag0339.
5
Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice.维持抗体稳定性并降低小鼠毒性的效应减弱性替代。
J Biol Chem. 2017 Mar 3;292(9):3900-3908. doi: 10.1074/jbc.M116.767749. Epub 2017 Jan 11.
6
TIGIT: A Key Inhibitor of the Cancer Immunity Cycle.TIGIT:癌症免疫循环的关键抑制剂。
Trends Immunol. 2017 Jan;38(1):20-28. doi: 10.1016/j.it.2016.10.002. Epub 2016 Oct 25.
7
The PD-1/PD-L1 inhibitory pathway is altered in pre-eclampsia and regulates T cell responses in pre-eclamptic rats.PD-1/PD-L1抑制通路在子痫前期中发生改变,并调节子痫前期大鼠的T细胞反应。
Sci Rep. 2016 Jun 9;6:27683. doi: 10.1038/srep27683.
8
Activation of Nod1 Signaling Induces Fetal Growth Restriction and Death through Fetal and Maternal Vasculopathy.Nod1信号通路的激活通过胎儿和母体血管病变诱导胎儿生长受限和死亡。
J Immunol. 2016 Mar 15;196(6):2779-87. doi: 10.4049/jimmunol.1500295. Epub 2016 Feb 15.
9
Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation?不明原因复发性流产与反复种植失败:免疫调节是否可行?
Am J Reprod Immunol. 2016 Jul;76(1):8-28. doi: 10.1111/aji.12493. Epub 2016 Feb 5.
10
Identification of CD112R as a novel checkpoint for human T cells.鉴定CD112R作为人类T细胞的一个新的检查点。
J Exp Med. 2016 Feb 8;213(2):167-76. doi: 10.1084/jem.20150785. Epub 2016 Jan 11.